Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 15,557 | 668 | 215 | 97 | 231 |
| Operating Income | -15,557 | -668 | -215 | -97 | -231 |
| Interest Expense | 290 | 0 | 0 | 0 | 0 |
| Other Income | -95 | -97 | -1 | 0 | 0 |
| Pre-tax Income | -15,941 | -765 | -216 | -97 | -231 |
| Income Tax | N/A | N/A | -1 | N/A | N/A |
| Net Income Continuous | -15,941 | -765 | -215 | -97 | -231 |
| Net Income | $-15,941 | $-766 | $-216 | $-97 | $-231 |
| EPS Basic Total Ops | -504.88 | -33.03 | -12.01 | 0.00 | -12.01 |
| EPS Basic Continuous Ops | -504.87 | -33.29 | -9.37 | -4.22 | -10.05 |
| EPS Diluted Total Ops | -504.88 | -33.03 | -12.01 | 0.00 | -12.01 |
| EPS Diluted Continuous Ops | -504.87 | -33.29 | -9.37 | -4.22 | -10.05 |
| EPS Diluted Before Non-Recurring Items | -504.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-15,557 | $-668 | $-215 | $-97 | $-231 |